Search

Author/Creator Phillips, Tycel

1. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas. Issue 12 (25th September 2017)

Authors:
Boonstra, Philip S.; Polk, Avery; Brown, Noah; Hristov, Alexandra C.; Bailey, Nathanael G.; Kaminski, Mark S.; Phillips, Tycel; Devata, Sumana; Mayer, Tera; Wilcox, Ryan A.
Journal:
American journal of hematology
Issue:
Volume 92:Issue 12(2017:Dec.)
Page Start:
1287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Issue 12 (20th April 2023)

Authors:
Thieblemont, Catherine; Phillips, Tycel; Ghesquieres, Herve; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Do, Young Rok; Feldman, Tatyana; Gasiorowski, Robin; Jurczak, Wojciech; Kim, Tae Min; Lewis, David John; van der Poel, Marjolein; Poon, Michelle Limei; Cota Stirner, Mariana; Ki...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 12(2023)
Page Start:
2238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pembrolizumab in relapsed or refractory Richter syndrome. (16th June 2020)

Authors:
Armand, Philippe; Murawski, Niels; Molin, Daniel; Zain, Jasmine; Eichhorst, Barbara; Gulbas, Zafer; Hawkes, Eliza A.; Pagel, John M.; Phillips, Tycel; Ribrag, Vincent; Svoboda, Jakub; Stathis, Anastasios; Chatterjee, Arkendu; Orlowski, Robert; Marinello, Patricia; Christian, Beth
Journal:
British journal of haematology
Issue:
Volume 190:Number 2(2020)
Page Start:
e117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*. Issue 9 (29th July 2021)

Authors:
Wilson, Wyndham H.; Phillips, Tycel; Popplewell, Leslie; de Vos, Sven; Chhabra, Saurabh; Kimball, Amy S.; Beaupre, Darrin; Huang, Da Wei; Wright, George; Kwei, Kevin; Ping, Jerry; Neuenburg, Jutta K.; Staudt, Louis M.
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 9(2021)
Page Start:
2094
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. RB but not R‐HCVAD is a feasible induction regimen prior to auto‐HCT in frontline MCL: results of SWOG Study S1106. (19th December 2016)

Authors:
Chen, Robert W.; Li, Hongli; Bernstein, Steven H.; Kahwash, Samir; Rimsza, Lisa M.; Forman, Stephen J.; Constine, Louis; Shea, Thomas C.; Cashen, Amanda F.; Blum, Kristie A.; Fenske, Timothy S.; Barr, Paul M.; Phillips, Tycel; Leblanc, Michael; Fisher, Richard I.; Cheson, Bruce D.; Smith, Sonali ...
Journal:
British journal of haematology
Issue:
Volume 176:Number 5(2017)
Page Start:
759
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma. Issue 1 (6th November 2019)

Authors:
Herrera, Alex F.; Goy, Andre; Mehta, Amitkumar; Ramchandren, Radhakrishnan; Pagel, John M.; Svoboda, Jakub; Guan, Shanhong; Hill, John S.; Kwei, Kevin; Liu, Emily A.; Phillips, Tycel
Journal:
American journal of hematology
Issue:
Volume 95:Issue 1(2020:Jan.)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study. Issue 1 (30th November 2021)

Authors:
Phillips, Tycel; Brunvand, Mark; Chen, Andy I.; Essell, James; Chiappella, Annalisa; Diefenbach, Catherine; Cheng, Ji; Ramies, David; Hirata, Jamie; Morschhauser, Franck; Flinn, Ian W.
Journal:
American journal of hematology
Issue:
Volume 97:Issue 1(2022)
Page Start:
E24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case report. (April 2019)

Authors:
Ettleson, Matthew; Bongers, Kale S; Vitale, Kaitlyn; Perissinotti, Anthony J.; Phillips, Tycel; Marini, Bernard L.
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 25:Number 3(2019)
Page Start:
731
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗